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Résumé en
anglais
We report the results of molecular screening in 980 patients carried out as part of
their work-up for suspected hereditary optic neuropathies. All the patients were
investigated for Leber's hereditary optic neuropathy (LHON) and autosomal
dominant optic atrophy (ADOA), by searching for the ten primary LHON-causing
mtDNA mutations and examining the entire coding sequences of the OPA1 and
OPA3 genes, the two genes currently identified in ADOA. Molecular defects were
identified in 440 patients (45% of screened patients). Among these, 295 patients
(67%) had an OPA1 mutation, 131 patients (30%) had an mtDNA mutation, and 14
patients (3%), belonging to three unrelated families, had an OPA3 mutation.
Interestingly, OPA1 mutations were found in 157 (40%) of the 392 apparently
sporadic cases of optic atrophy. The eOPA1 locus-specific database now contains a
total of 204 OPA1 mutations, including 77 novel OPA1 mutations reported here. The
statistical analysis of this large set of mutations has led us to propose a diagnostic
strategy that should help with the molecular work-up of optic neuropathies. Our
results highlight the importance of investigating LHON-causing mtDNA mutations
as well as OPA1 and OPA3 mutations in cases of suspected hereditary optic
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